OFI Advisors’s AbbVie ABBV Stock Holding History

OFI Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$1.64M	Buy	30,195 +2,870	+11%	+$187K	0.11%	184
2015 Q2	$1.84M	Sell	27,325 -1,825	-6%	-$119K	0.11%	185
2015 Q1	$1.71M	Buy	29,150 +5,245	+22%	+$317K	0.1%	204
2014 Q4	$1.56M	Sell	23,905 -1,315	-5%	-$82.9K	0.1%	201
2014 Q3	$1.46M	Sell	25,220 -1,987	-7%	-$110K	0.1%	190
2014 Q2	$1.54M	Buy	27,207 +1,866	+7%	+$97.9K	0.11%	181
2014 Q1	$1.3M	Buy	25,341 +1,830	+8%	+$92.5K	0.1%	196
2013 Q4	$1.24M	Sell	23,511 -434	-2%	-$21.3K	0.1%	192
2013 Q3	$1.07M	Sell	23,945 -8,165	-25%	-$362K	0.1%	186
2013 Q2	$1.33M	Buy	+32,110	New	+$1.4M	0.14%	141

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

OFI Advisors's ABBV Position: Q3 2015 in Review

OFI Advisors increased its AbbVie (ABBV) stake by 11% in Q3 2015, buying an estimated $187K and bringing the position to 30,195 shares worth $1.64M. The position accounts for 0.11% of the portfolio, ranked #184.

OFI Advisors first reported a position in ABBV in Q2 2013 and has held it in 10 quarters since. The position peaked at $1.84M in Q2 2015. 1,605 funds tracked by Wall St. Rank hold ABBV as of Q3 2015.

OFI Advisors held 30,195 shares of AbbVie worth $1.64M as of Q3 2015.
OFI Advisors bought 2,870 AbbVie shares in Q3 2015, an estimated $187K.
AbbVie made up 0.11% of OFI Advisors's portfolio in Q3 2015, its #184 holding.
OFI Advisors first reported a position in AbbVie in Q2 2013 and has held it in 10 quarters since.
OFI Advisors's AbbVie position peaked at $1.84M in Q2 2015.
1,605 funds tracked by Wall St. Rank held AbbVie as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.